Journey Medical CorporationDERMNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank30
3Y CAGR+28.7%
5Y CAGR-19.7%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+28.7%/yr
vs -69.4%/yr prior
5Y CAGR
-19.7%/yr
Recent acceleration
Acceleration
+98.1pp
Accelerating
Percentile
P30
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 1.52 | +26.2% |
| 2023 | 1.20 | +260.1% |
| 2022 | 0.33 | -53.1% |
| 2021 | 0.71 | -80.2% |
| 2020 | 3.59 | -21.0% |
| 2019 | 4.55 | -68.3% |
| 2018 | 14.36 | -82.3% |
| 2017 | 81.22 | +316.7% |
| 2016 | 19.49 | -62.0% |
| 2015 | 51.33 | - |